Literature DB >> 27824840

Hope for anti-amyloid antibodies surges, yet again.

Chris Morrison.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27824840     DOI： 10.1038/nbt1116-1082b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  J&J's billion dollar punt on anti-amyloid antibody.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2009-08       Impact factor: 54.908

2.  Pivotal trials for β-secretase inhibitors in Alzheimer's.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2015-02       Impact factor: 54.908

3.  Genentech's Alzheimer's antibody trial to study disease prevention.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2012-08       Impact factor: 54.908

4.  The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

Authors:  Jeff Sevigny; Ping Chiao; Thierry Bussière; Paul H Weinreb; Leslie Williams; Marcel Maier; Robert Dunstan; Stephen Salloway; Tianle Chen; Yan Ling; John O'Gorman; Fang Qian; Mahin Arastu; Mingwei Li; Sowmya Chollate; Melanie S Brennan; Omar Quintero-Monzon; Robert H Scannevin; H Moore Arnold; Thomas Engber; Kenneth Rhodes; James Ferrero; Yaming Hang; Alvydas Mikulskis; Jan Grimm; Christoph Hock; Roger M Nitsch; Alfred Sandrock
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

5.  Biogen's early Alzheimer's data raise hopes, some eyebrows.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2015-05       Impact factor: 54.908
  5 in total
  3 in total

1.  Attenuation of HECT-E3 ligase expression rescued memory deficits in 3xTg-AD mice.

Authors:  Pavithra Suresh; Sureka Jasmin; Yun Yen; Hao-Jen Hsu; Peeraporn Varinthra; Tanita Pairojana; Chien-Chang Chen; Ingrid Y Liu
Journal:  Front Aging Neurosci       Date:  2022-07-29       Impact factor: 5.702

2.  Lung adenocarcinoma-related target gene prediction and drug repositioning.

Authors:  Rui Xuan Huang; Damrongrat Siriwanna; William C Cho; Tsz Kin Wan; Yan Rong Du; Adam N Bennett; Qian Echo He; Jun Dong Liu; Xiao Tai Huang; Kei Hang Katie Chan
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

3.  Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets.

Authors:  Yaqiong Dong; Tessandra Stewart; Lidan Bai; Xue Li; Ting Xu; Jeffrey Iliff; Min Shi; Danfeng Zheng; Lan Yuan; Taotao Wei; Xiaoda Yang; Jing Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.